Related Experiment Videos
[The use of holoxan (iphosphamide) in malignant tumors]
Voprosy Onkologii
|January 1, 1990
Abstract:
A clinical trial of holoxan in combination with a urological protector--uromitexan--was carried out. Response was observed in 26.3% of patients with lung cancer. The drug was effective in cases of soft tissue sarcoma and Ewing's sarcoma.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Effects of fullerenol C₆₀(OH)₂₄ on erythropoiesis in vitro.
Bulletin of experimental biology and medicine·2014
[Which patients with ovarian cancer shows the combination of trabectedin with pegylated liposomal doxorubicin].
Vestnik Rossiiskoi akademii meditsinskikh nauk·2014
[The application of immunoglobulins for intravenous administration for the combined treatment of paratonsillar abscesses].
Vestnik otorinolaringologii·2012
[Experience in treating elderly patients with disseminated stomach and colon cancer].
Advances in gerontology = Uspekhi gerontologii·2003
[Diagnostic errors in patients with giant-cell tumor, bone cyst and osteosarcoma].
Voprosy onkologii·2019
[Inhibitory effect of RHAMM-target peptides on invasion of breast cancer cells].
Voprosy onkologii·2019
[Possibilities of local hyperthermia in treatment for edematous breast cancer patients].
Voprosy onkologii·2019
[Experience of 100 transthoracic needle biopsies of the lung under CT navigation].
Voprosy onkologii·2019
Post-diagnosis cannabis use and its association with health status and quality of life in cancer survivors.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Aloesin mitigates cisplatin-induced nephrotoxicity by suppressing NF-κB-mediated oxidative stress and modulating Bax/Bcl-2/caspase pathways.
Naunyn-Schmiedeberg's archives of pharmacology·2026